WebClick to view Hydrea detailed prescribing information Dosage/Direction for Use Solid tumors Continuous therapy: 20-30 mg/kg daily as a single dose. Intermittent therapy: 80 mg/kg as single doses given every 3rd day. Carcinoma of the head, neck & cervix Concomitant therapy w/ irradiation: 80 mg/kg in single doses given every 3rd day. WebFULL PRESCRIBING INFORMATION: CONTENTS* 1 INDICATIONS AND USAGE 1.1 Newly Diagnosed Philadelphia Positive Chronic Myeloid Leukemia (Ph+ CML) 1.2 Ph+ CML in Blast Crisis (BC), Accelerated Phase (AP) or Chronic Phase (CP) After Interferon-alpha (IFN) Therapy 1.3 Adult Patients With Ph+ Acute Lymphoblastic Leukemia (ALL)
HIGHLIGHTS OF PRESCRIBING INFORMATION - Food and Drug Administration
WebHallucinaties, desoriëntatie. Perifere neuropathie, slaperigheid, neurologische stoornissen (o.a. hoofdpijn, duizeligheid, convulsie). Longfibrose, longoedeem, acute pulmonale reacties (diffusie pulmonale infiltraten, koorts, dyspneu). Hepatotoxiciteit, stijging leverenzymwaarden, cholestase, hepatitis. Soms (0,1-1%): k Actinische keratose. WebBrand names: Droxia, Hydrea, Mylocel. What is hydroxyurea? Hydroxyurea affects certain cells in the body, such as cancer cells or sickled red blood cells. Hydroxyurea is used to treat chronic myelocytic leukemia, ovarian cancer, and certain types of skin cancer (melanoma and primary squamous cell cancer of the head and neck). koers thermo fisher scientific
Hydroxyurea for Sickle Cell Disease - American Society of …
Web23 mrt. 2024 · Hydrea ( hydroxyurea) is an antineoplastic (anti-cancer) agent used to treat melanoma, resistant chronic myelocytic leukemia, and recurrent, metastatic, or inoperable carcinoma of the ovary and primary squamous cell (epidermoid) carcinomas of the head and neck. Hydrea is available in generic form. What Are Side Effects of Hydrea? Web17 feb. 2024 · Prophylactic administration of folic acid is recommended. Chronic myeloid leukemia (Hydrea): Oral: Initial: 40 mg/kg/day (reduce initial dose for thrombocytopenia); reduce dose to 20 mg/kg/day if WBC count <2,000/mm 3. Further individualize dose based on WBC counts (Hehlmann 1993). WebMATULANE® (procarbazine hydrochloride) Indication: Matulane is indicated for use in combination with other anticancer drugs for the treatment of Stage III and IV Hodgkin’s disease. Matulane is used as part of the MOPP (nitrogen mustard, vincristine, procarbazine, prednisone) regimen. Please see full Prescribing Information for Matulane ... redfern town hall booster